{"id":13192,"date":"2020-06-15T14:42:00","date_gmt":"2020-06-15T05:42:00","guid":{"rendered":"https:\/\/microncro.com\/?p=13192"},"modified":"2026-05-18T15:50:29","modified_gmt":"2026-05-18T06:50:29","slug":"covid-19_achievement","status":"publish","type":"post","link":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/","title":{"rendered":"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection"},"content":{"rendered":"\n<p class=\"is-small-size\">A programmed medical device powered by artificial intelligence (AI), developed with support from Micron, Inc. (Micron), has received the first approval in Japan as a \u201cPulmonary imaging analysis program related to novel coronavirus infection\u201d on June 3rd, 2020.<\/p>\n\n\n\n<p class=\"is-small-size\">Micron\u2019s Clinical Development Support Department has been contracted by CES Descartes Co., Ltd. (Marketing Authorization Holders) (Manufactured by Beijing Infervision Technology Co., Ltd.) to perform the following: study protocol preparation, central imaging review organization, statistical analysis, documentation and whole application process support. We\u2019re proud to have obtained PMDA approval at a remarkable speed of around two (2) months after contract execution.<\/p>\n\n\n\n<p class=\"is-small-size\">In addition to contributing solutions to the novel coronavirus infection, providing support to the global social crisis, we will continue to enhance our regulatory approval support for medical devices equipped with AI, which are expected to grow in the future with the know-how obtained at this time.<\/p>\n\n\n\n<p class=\"is-small-size\">CES Descartes Co., Ltd.<\/p>\n\n\n\n<p class=\"is-small-size\">Obtained approval for a medical device for symptoms related to COVID-19 infection (<a href=\"http:\/\/desc.co.jp\/covid-19\/\" target=\"_blank\" rel=\"noreferrer noopener\">http:\/\/desc.co.jp\/covid-19\/<\/a>)<br>PMDA (<a href=\"https:\/\/www.pmda.go.jp\/about-pmda\/news-release\/0012.html\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.pmda.go.jp\/about-pmda\/news-release\/0012.html<\/a>)<br>Ministry of Health, Labour and Welfare (<a href=\"https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/000011639.html\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/000011639.html<\/a>)<\/p>\n\n\n\n<p class=\"is-small-size\">If you have any questions regarding this announcement, please contact us at:<\/p>\n\n\n\n<p class=\"is-small-size\">info@micron-kobe.com<\/p>\n\n\n\n\n<div class=\"micron-share\">\n\t<div class=\"micron-share-inner\">\n\t\t<h2 class=\"micron-share-title\">Share<\/h2>\n\t\t<ul class=\"micron-share-buttons\">\n\t\t\t<li><a class=\"micron-share-button-linkedin\" href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/\" rel=\"nofollow\" target=\"_blank\">LinkedIn \u3067\u30b7\u30a7\u30a2\u3059\u308b<\/a><\/li>\n\t\t<\/ul>\n\t<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A programmed medical device powered by artificial intelligence (AI), developed with support from Micron, Inc. (Micron), has received the first approval in Japan as a \u201cPulmonary imaging analysis program related to novel coronavirus infection\u201d on June 3rd, 2020. Micron\u2019s Clinical Development Support Department has been contracted by CES Descartes Co., Ltd. (Marketing Authorization Holders) (Manufactured [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/microncro.com\/?p=11721","footnotes":""},"categories":[31],"class_list":["post-13192","post","type-post","status-publish","format-standard","hentry","category-news","en-US"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Micron\u2019s achievement related to novel coronavirus (COVID-19) infection | Micron, Inc. | Molecular Imaging CRO Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection | Micron, Inc. | Molecular Imaging CRO Network\" \/>\n<meta property=\"og:description\" content=\"A programmed medical device powered by artificial intelligence (AI), developed with support from Micron, Inc. (Micron), has received the first approval in Japan as a \u201cPulmonary imaging analysis program related to novel coronavirus infection\u201d on June 3rd, 2020. Micron\u2019s Clinical Development Support Department has been contracted by CES Descartes Co., Ltd. (Marketing Authorization Holders) (Manufactured [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/\" \/>\n<meta property=\"og:site_name\" content=\"Micron, Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-15T05:42:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-18T06:50:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"info@digitalcube.jp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info@digitalcube.jp\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/\"},\"author\":{\"name\":\"info@digitalcube.jp\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/person\\\/122c381484536eeb18bd40a8b8e47aaf\"},\"headline\":\"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection\",\"datePublished\":\"2020-06-15T05:42:00+00:00\",\"dateModified\":\"2026-05-18T06:50:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/\"},\"wordCount\":215,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/\",\"name\":\"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection | \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3 | Molecular Imaging CRO Network\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\"},\"datePublished\":\"2020-06-15T05:42:00+00:00\",\"dateModified\":\"2026-05-18T06:50:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/covid-19_achievement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/microncro.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"description\":\"Molecular Imaging CRO Network\",\"publisher\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/microncro.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"contentUrl\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"width\":1200,\"height\":630,\"caption\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\"},\"image\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/person\\\/122c381484536eeb18bd40a8b8e47aaf\",\"name\":\"info@digitalcube.jp\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"caption\":\"info@digitalcube.jp\"},\"sameAs\":[\"https:\\\/\\\/microncro.com\"],\"url\":\"https:\\\/\\\/microncro.com\\\/archives\\\/post\\\/author\\\/infodigitalcube-jp\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection | Micron, Inc. | Molecular Imaging CRO Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/","og_locale":"en_US","og_type":"article","og_title":"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection | Micron, Inc. | Molecular Imaging CRO Network","og_description":"A programmed medical device powered by artificial intelligence (AI), developed with support from Micron, Inc. (Micron), has received the first approval in Japan as a \u201cPulmonary imaging analysis program related to novel coronavirus infection\u201d on June 3rd, 2020. Micron\u2019s Clinical Development Support Department has been contracted by CES Descartes Co., Ltd. (Marketing Authorization Holders) (Manufactured [&hellip;]","og_url":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/","og_site_name":"Micron, Inc.","article_published_time":"2020-06-15T05:42:00+00:00","article_modified_time":"2026-05-18T06:50:29+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","type":"image\/png"}],"author":"info@digitalcube.jp","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info@digitalcube.jp","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/#article","isPartOf":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/"},"author":{"name":"info@digitalcube.jp","@id":"https:\/\/microncro.com\/#\/schema\/person\/122c381484536eeb18bd40a8b8e47aaf"},"headline":"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection","datePublished":"2020-06-15T05:42:00+00:00","dateModified":"2026-05-18T06:50:29+00:00","mainEntityOfPage":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/"},"wordCount":215,"commentCount":0,"publisher":{"@id":"https:\/\/microncro.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/","url":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/","name":"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection | \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3 | Molecular Imaging CRO Network","isPartOf":{"@id":"https:\/\/microncro.com\/#website"},"datePublished":"2020-06-15T05:42:00+00:00","dateModified":"2026-05-18T06:50:29+00:00","breadcrumb":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/microncro.com\/en\/archives\/post\/covid-19_achievement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microncro.com\/en\/"},{"@type":"ListItem","position":2,"name":"Micron\u2019s achievement related to novel coronavirus (COVID-19) infection"}]},{"@type":"WebSite","@id":"https:\/\/microncro.com\/#website","url":"https:\/\/microncro.com\/","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","description":"Molecular Imaging CRO Network","publisher":{"@id":"https:\/\/microncro.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microncro.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/microncro.com\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","url":"https:\/\/microncro.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/","url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","contentUrl":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","width":1200,"height":630,"caption":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3"},"image":{"@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/microncro.com\/#\/schema\/person\/122c381484536eeb18bd40a8b8e47aaf","name":"info@digitalcube.jp","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","caption":"info@digitalcube.jp"},"sameAs":["https:\/\/microncro.com"],"url":"https:\/\/microncro.com\/archives\/post\/author\/infodigitalcube-jp\/"}]}},"_links":{"self":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/13192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/comments?post=13192"}],"version-history":[{"count":2,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/13192\/revisions"}],"predecessor-version":[{"id":13782,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/13192\/revisions\/13782"}],"wp:attachment":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/media?parent=13192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/categories?post=13192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}